Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Scrutiniser''s Report On The Postal Ballot

This refers to the Postal Ballot Notice dated 29th July, 2022 sent to the shareholders of the Company seeking their approval on the items as detailed in the Notice. The e-voting facility to shareholders was provided through Central Depository Services (India) Limited. The e-voting period commenced on Wednesday, 10th August, 2022 from 9:00 am and ended on Thursday, 08th September, 2022 at 5:00 pm. Rajesh Parekh, Practicing Company Secretary & Scrutinizer, appointed by the Board, has submitted his report on the result of Postal Ballot and based on the said report Samir Mehta, Chairman has announced the results of the Postal Ballot, copy of the same is enclosed herewith. The results of the postal ballot under Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") is being submitted separately.
09-09-2022

Pharma stock trading near 52-week high. Here's what Jefferies suggests

Torrent Pharma has been leveraging its balance sheet to pump up its P&L through acquisitions, said Jefferies
03-09-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Reporting (BRSR)
01-09-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Redemption Of Non-Convertible Debentures

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures (NCDs) of Rs 300 crores (Rupees Three Hundred Crores) issued under ISIN: INE685A07090 has been fully redeemed and repaid by the Company on 30-Aug-22.
30-08-2022

Rise of cosmetic dermatology space gets big pharma looking for buyouts

According to reports, Torrent Pharmaceuticals is set to sign a deal to acquire Curatio Healthcare, a maker of skincare products, for Rs 2100 crore.
26-08-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Clarification / Information On News Item

This is with reference to e-mail received from BSE on 25th August, 2022, referring to the news item appeared in https://economictimes.indiatimes.com captioned 'Torrent Pharma set to acquire Curatio' and letter received from NSE bearing reference no. NSE/CM/Surveillance/12213 dated 25th August, 2022, referring to Clarification /Confirmation on news item appearing in the 'Website-www.economictimes.com' dated August 25, 2022 captioned 'Torrent Pharma set to acquire Curatio'. Please note that it is the company's policy not to respond to any speculative news items. As a growing Company, we do continuously scout for the business opportunities, both organic and inorganic. As a responsible listed organization, we inform the Exchanges all events, information which are required to be disclosed in accordance with terms of Regulation 30 of SEBI Listing Regulations, 2015. We have always abided by and complied with all regulatory requirements and will continue to do so.
25-08-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that ICRA Limited has upgraded the long term credit rating of banking facilities and non-convertible debentures of the Company to 'ICRA AA+/Stable' from 'ICRA AA/Positive'. ICRA has reaffirmed its rating on commercial paper programme at ICRA A1+. The Rationale for the same as issued by ICRA Limited is enclosed herewith.
25-08-2022
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Clarification sought from Torrent Pharmaceuticals Ltd

The Exchange has sought Clarification from Torrent Pharmaceuticals Ltd with reference to the media report appearing on https://economictimes.indiatimes.com dated August 25, 2022 (Link : https://economictimes.indiatimes.com/markets/stocks/news/torrent-pharma-set-to-acquire-curatio/articleshow/93763767.cms) titled "Torrent Pharma set to acquire Curatio"The reply is awaited.
25-08-2022

Torrent Pharma set to acquire Curatio

The transaction will see the exit of existing investors of Curatio, such as ChrysCapital (which holds a 20% stake) and Sequoia Capital (33%). Promoters, including GK Ramani, and the management will also be exiting the company.
25-08-2022
Next Page
Close

Let's Open Free Demat Account